Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DS-3078a |
| Synonyms | |
| Therapy Description |
DS-3078a is a small molecule that inhibits mTOR kinase activity and downstream signaling, resulting in decreased tumor cell growth (Mol Cancer Ther 2013;12(11 Suppl):B184). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DS-3078a | mTOR Inhibitor 51 | DS-3078a is a small molecule that inhibits mTOR kinase activity and downstream signaling, resulting in decreased tumor cell growth (Mol Cancer Ther 2013;12(11 Suppl):B184). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT01588678 | Phase I | DS-3078a | A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas | Completed | USA | 0 |